Overview
- Rush University Medical Center paused puberty blockers and hormone replacement therapy for new patients under 18 starting July 1.
- Existing minor patients may continue treatments only if halting care would risk harm to their health.
- The hospital will still offer mental health, behavioral health and social services to all gender care patients and full medical gender-affirming services to adults.
- Rush’s decision follows President Trump’s January executive order threatening to withdraw federal research grants and Medicare and Medicaid reimbursements.
- Similar suspensions at Lurie Children’s and UI Health reflect a broader trend as providers respond to federal enforcement and DOJ subpoenas of patient records.